Subscribe to our feed.

Purdue startup commercializing innovation to reduce neurotoxin that damages nerve cells, triggers pain

September 16, 2014 — WEST LAFAYETTE, Ind. – A Purdue startup is commercializing a technology that could reduce the symptoms and pain of neurological disease and injury, including multiple sclerosis, neuropathic pain and Parkinson's disease.The innovation developed by Neuro Vigor LLC could reduce the symptoms and pain by identifying and lowering the amount of a neurotoxin, called acrolein, that rises with disease and injury, and whose reduction has potential to yield significant therapeutic benefits.  Read More